{
    "id": 24077,
    "fullName": "POLE V411L",
    "impact": "missense",
    "proteinEffect": "loss of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "POLE V411L lies within the exonuclease domain of the Pole protein (PMID: 29352080). V411L results in reduced Pole exonuclease activity in an in vitro assay (PMID: 25228659), and therefore, is predicted to lead to a loss of Pole protein function.",
            "references": [
                {
                    "id": 13143,
                    "pubMedId": 29352080,
                    "title": "Functional Analysis of Cancer-Associated DNA Polymerase \u03b5 Variants in Saccharomyces cerevisiae.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29352080"
                },
                {
                    "id": 6258,
                    "pubMedId": 25228659,
                    "title": "Exonuclease mutations in DNA polymerase epsilon reveal replication strand specific mutation patterns and human origins of replication.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25228659"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5426,
        "geneSymbol": "POLE",
        "terms": [
            "POLE",
            "CRCS12",
            "FILS",
            "IMAGEI",
            "POLE1"
        ]
    },
    "variant": "V411L",
    "createDate": "07/07/2016",
    "updateDate": "08/06/2019",
    "referenceTranscriptCoordinates": {
        "id": 173035,
        "transcript": "NM_006231",
        "gDna": "chr12:g.132673703C>G",
        "cDna": "c.1231G>C",
        "protein": "p.V411L",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 7251,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case report, Keytruda (pembrolizumab) treatment resulted in quick clinical improvement and a partial response lasting over 14 months in a patient with endometrial adenocarcinoma that was PD-L1 (CD274)-positive, harbored POLE V411L and R114*, and had high tumor mutational burden (PMID: 27159395).",
            "molecularProfile": {
                "id": 31370,
                "profileName": "CD274 pos POLE R114* POLE V411L TMB high"
            },
            "therapy": {
                "id": 1447,
                "therapyName": "Pembrolizumab",
                "synonyms": null
            },
            "indication": {
                "id": 2870,
                "name": "endometrial adenocarcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 6260,
                    "pubMedId": 27159395,
                    "title": "Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27159395"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 24805,
            "profileName": "POLE V411L",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 24807,
            "profileName": "CD274 pos POLE R114* POLE V411L",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 31370,
            "profileName": "CD274 pos POLE R114* POLE V411L TMB high",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 173038,
            "transcript": "XM_011534799",
            "gDna": "chr12:g.132673703C>G",
            "cDna": "c.1231G>C",
            "protein": "p.V411L",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 173035,
            "transcript": "NM_006231",
            "gDna": "chr12:g.132673703C>G",
            "cDna": "c.1231G>C",
            "protein": "p.V411L",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 173037,
            "transcript": "XM_011534800",
            "gDna": "chr12:g.132673703C>G",
            "cDna": "c.1231G>C",
            "protein": "p.V411L",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 173036,
            "transcript": "XM_011534795",
            "gDna": "chr12:g.132673703C>G",
            "cDna": "c.1231G>C",
            "protein": "p.V411L",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}